ATE257713T1 - Verwendung lebender abgeschwächter bakterien zur herstellung eines submukosalen impstoffes - Google Patents
Verwendung lebender abgeschwächter bakterien zur herstellung eines submukosalen impstoffesInfo
- Publication number
- ATE257713T1 ATE257713T1 AT00200216T AT00200216T ATE257713T1 AT E257713 T1 ATE257713 T1 AT E257713T1 AT 00200216 T AT00200216 T AT 00200216T AT 00200216 T AT00200216 T AT 00200216T AT E257713 T1 ATE257713 T1 AT E257713T1
- Authority
- AT
- Austria
- Prior art keywords
- vaccine
- submucosal
- live
- produce
- bacteria
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/82—Viral vaccine for equine species, e.g. horses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/829—Bacterial vaccine for equine species, e.g. horses
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99200202 | 1999-01-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE257713T1 true ATE257713T1 (de) | 2004-01-15 |
Family
ID=8239828
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00200216T ATE257713T1 (de) | 1999-01-26 | 2000-01-20 | Verwendung lebender abgeschwächter bakterien zur herstellung eines submukosalen impstoffes |
Country Status (10)
Country | Link |
---|---|
US (2) | US20040120970A1 (de) |
EP (1) | EP1023903B1 (de) |
JP (1) | JP4339978B2 (de) |
AT (1) | ATE257713T1 (de) |
AU (1) | AU761515B2 (de) |
CA (1) | CA2296965A1 (de) |
DE (1) | DE60007668T2 (de) |
DK (1) | DK1023903T3 (de) |
ES (1) | ES2214217T3 (de) |
PT (1) | PT1023903E (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0315323D0 (en) | 2003-07-01 | 2003-08-06 | Royal Veterinary College | Vaccine composition |
US9023366B2 (en) | 2003-07-01 | 2015-05-05 | The Royal Veterinary College | Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD) |
EP3895737A1 (de) * | 2007-06-29 | 2021-10-20 | Stelic Institute Of Regenerative Medicine, Stelic Institute & Co. | Verfahren zur fixierung und expression einer physiologisch aktiven substanz |
GB0801326D0 (en) | 2008-01-24 | 2008-03-05 | Animal Health Trust | Vaccines |
KR101210082B1 (ko) * | 2010-10-15 | 2012-12-07 | 주식회사 동방 | 돼지 다발성 장막염 예방용 백신 조성물 및 그 제조방법 |
KR101694676B1 (ko) * | 2015-12-10 | 2017-01-10 | 우진 비앤지 주식회사 | 말 선역 질병원인 국내 분리 스트렙토코커스 이콰이 균주 및 이를 포함하는 백신 |
CA3108051A1 (en) | 2018-08-10 | 2020-02-13 | Meiji Seika Pharma Co., Ltd. | Bacteriophage preparation |
CN112973157A (zh) * | 2021-02-04 | 2021-06-18 | 广西田东锦盛化工有限公司 | 一种用于氯碱生产的盐水浓缩装置 |
CN113244664A (zh) * | 2021-05-12 | 2021-08-13 | 伍俊雄 | 一种用于疫苗破乳及分离的装置 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2033223B (en) * | 1978-09-01 | 1983-09-14 | Secr Social Service Brit | Antigen fromstreptococcus mutans for protection against dental caries |
JPS6037734B2 (ja) | 1978-10-12 | 1985-08-28 | 住友電気工業株式会社 | 管状臓器補綴材及びその製造方法 |
US4521513A (en) | 1981-06-19 | 1985-06-04 | The Secretary Of State Of Social Services In Her Britannic Majesty's Government Of The United Kingdon Of Great Brtian And Northern Ireland | Protection against dental caries |
IE940698L (en) | 1984-04-05 | 1985-10-05 | Univ Missouri | Vaccine and serum for endotoxin associated disease and method of preparing same as well as to methods of immunization and treatment of such disease and to a detoxified endotoxin and bacterial mutant |
AR241545A1 (es) * | 1985-07-12 | 1992-08-31 | Cornell Res Foundation Inc | Un metodo para preparar una cepa de s. equi avirulenta a.t.c.c. 53186 para equinos. |
BE1008103A3 (fr) | 1994-04-22 | 1996-01-16 | Pantochim Sa | Procede de preparation de catalyseurs au vanadium et phosphore et leur utilisation pour la production d'anhydride maleique. |
ZA97452B (en) | 1996-01-25 | 1997-08-15 | Trinity College Dublin | Streptococcus equi vaccine. |
US5895756A (en) | 1997-04-11 | 1999-04-20 | The Board Of Trustees Of The University Of Texas System | Non-antibiotic system for selection of recombinant mycobacteria |
CA2243730C (en) * | 1997-07-29 | 2009-12-22 | Akzo Nobel N.V. | Streptococcus equi vaccine |
US6682745B1 (en) * | 1998-07-28 | 2004-01-27 | Christiaan Antonius Arnoldus Jacobs | Use of bacterium for manufacture of a vaccine |
US6344201B1 (en) | 1998-03-31 | 2002-02-05 | Anthony T. Maurelli | Methods of identifying bacterial genes that are incompatible with bacterial pathogenicity, and the use of such genes, such as cadA, to reduce pathogenicity in a bacteria or to combat pathogenic bacterial infections |
-
2000
- 2000-01-20 DK DK00200216T patent/DK1023903T3/da active
- 2000-01-20 JP JP2000011573A patent/JP4339978B2/ja not_active Expired - Fee Related
- 2000-01-20 ES ES00200216T patent/ES2214217T3/es not_active Expired - Lifetime
- 2000-01-20 AT AT00200216T patent/ATE257713T1/de not_active IP Right Cessation
- 2000-01-20 EP EP00200216A patent/EP1023903B1/de not_active Expired - Lifetime
- 2000-01-20 PT PT00200216T patent/PT1023903E/pt unknown
- 2000-01-20 DE DE60007668T patent/DE60007668T2/de not_active Expired - Lifetime
- 2000-01-25 AU AU13557/00A patent/AU761515B2/en not_active Ceased
- 2000-01-25 CA CA002296965A patent/CA2296965A1/en not_active Abandoned
-
2003
- 2003-12-08 US US10/731,724 patent/US20040120970A1/en not_active Abandoned
-
2010
- 2010-12-01 US US12/957,543 patent/US8084040B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
PT1023903E (pt) | 2004-04-30 |
JP2000309542A (ja) | 2000-11-07 |
AU761515B2 (en) | 2003-06-05 |
US8084040B2 (en) | 2011-12-27 |
DE60007668T2 (de) | 2004-12-02 |
DK1023903T3 (da) | 2004-05-10 |
CA2296965A1 (en) | 2000-07-26 |
AU1355700A (en) | 2000-07-27 |
US20040120970A1 (en) | 2004-06-24 |
DE60007668D1 (de) | 2004-02-19 |
EP1023903A1 (de) | 2000-08-02 |
EP1023903B1 (de) | 2004-01-14 |
ES2214217T3 (es) | 2004-09-16 |
JP4339978B2 (ja) | 2009-10-07 |
US20110123571A1 (en) | 2011-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE378403T1 (de) | Transchromosomale transgen-nagetiere zur herstellung von humänen antikörpern | |
ATE218154T1 (de) | Physikalisch modifizierte abbaubare thermoplastische zusammensetzung | |
DE69936845D1 (de) | Halbsynthetische ectein-ascidine | |
DE60114865D1 (de) | Heterologe herstellung von polyketiden | |
CY1105721T1 (el) | Δερματικοι αναισθητικοι παραγοντες | |
ATE257713T1 (de) | Verwendung lebender abgeschwächter bakterien zur herstellung eines submukosalen impstoffes | |
DE60026844D1 (de) | Verfahren zur herstellung von 3,3-dimethylbutanal | |
UA85543C2 (ru) | Способ культивирования первичных клеток и амплификации вирусов в условиях безсывороточной среды, композиция и ее применение, и способ лечения или вакцинации животных | |
ID26055A (id) | Senyawa-senyawa hidroksidifenil eter | |
DE60100858D1 (de) | Prozess zur herstellung der kristallinen form i von cabergolin | |
ATE231131T1 (de) | Verbindungen mit wachtumshormon freisetzenden eigenschaften | |
DE60125378D1 (de) | Verfahren zur herstellung von 2-aminomethyl-halogen-pyridinen | |
ATE307214T1 (de) | Verfahren zur herstellung einer aus pflanzen stammenden, antibakteriellen substanz | |
DE69824794D1 (de) | Streptococcus equi Impfstoff | |
ATE504309T1 (de) | Verwendung von oxytocin zur herstellung einer pharmazeutischen zusammensetzung gegen karzinom in situ und zervizitis | |
DE69924741D1 (de) | Verwendung einer zusammensetzung zur herstellung eines arzneimittels zur vorbeugung und behandlung von parodontitis | |
DE69901243T2 (de) | Artikulator zur herstellung von zahnärztlichen prothesen | |
ATE347905T1 (de) | Lebende attenuierte bakterien zur verwendung als impfstoff | |
ES2195500T3 (es) | Dereivados del 2-indanometanol y su utilizacion a titulo de ingredientes perfumantes. | |
ATE238261T1 (de) | Verfahren zur herstellung von orthoestern | |
DE60120985D1 (de) | Verwendung von fibrate zur herstellung eines arzneimittel zur behandlung von kongestiven herzversagens | |
DE69117974D1 (de) | Pharmazeutische zusammensetzungen zur behandlung von b-zell-entartungen | |
DE69718690D1 (de) | Verfahren zur Herstellung von optisch-aktivem 2-halogen-1-(substituiertes Phenyl)ethanol. | |
ATE266403T1 (de) | Verwendung von 2-methyl-thiazolidin 2,4- dicarbonsäure zur herstellung eines medikaments zur behandlung von infektionskrankheiten | |
ATE306471T1 (de) | Verfahren zur herstellung von biperiden iv |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1023903 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |